The CDC Pauses Johnson & Johnson Vaccine Distribution

April 13, 2021 2:34 pm Published by

The United States Centers for Disease Control (CDC) along with the Food and Drug Administration (FDA) said today that out of an abundance of precaution they will be pausing distribution of the one-shot Johnson & Johnson COVID-19 vaccine. The news comes after a series of reports of various state locations pause the vaccine due to severe side effects.

This news comes as the United States has vaccinated nearly 50% of all adults with at least one dose of a COVID-19 vaccine.

The CDC paused the Johnson & Johnson vaccine after 6 people experienced unusual blood clots which led to one death. The U.S. has administered 7.25 million doses of the Johnson & Johnson when the pause was initiated. The CDC will hold a special meeting to review the facts of the rare cases of blood clots and determine if the vaccine is still able to be used in the U.S.

Many states, including Connecticut, have said that while they are disappointed in the CDC’s decision they will likely be able to cover most vaccine appointments for residents with either the Moderna or Pfizer vaccines.

The state of Connecticut continues to outpace the rest of the country with vaccinations as almost 30% of all eligible adults have been fully vaccinated and just under 46% of all eligible adults have received at least one dose of the vaccine. This compares to 23% nationwide that are fully vaccinated and 37% who have received at least one dose.